Testosterone Patch's effects on cardiovascular system & libido (pilot)
Research type
Research Study
Full title
Pilot Study: Evaluating the effect of 300microgram testosterone patches in addition to Hormone Replacement Therapy on arterial compliance, insulin resistance and sexual desire
IRAS ID
26123
Contact name
Nick Panay
Sponsor organisation
Imperial College Healthcare NHS Trust
Eudract number
2009-013275-21
ISRCTN Number
not issued
Research summary
The aim of the study is to determine the effects of the testosterone patch, when used in conjunction with Hormone Replacement Therapy (HRT), on the arterial walls and on insulin sensitivity, in post-menopausal women. It will also assess the impact of testosterone replacement on libido.This study will act as a feasibility study with the aim to progressing to a randomised placebo-controlled trial.Reduction in testosterone in postmenopausal women is associated with reduced libido and testosterone replacement is increasingly used as treatment. Data on the safety of testosterone replacement on the cardiovascular system and on insulin sensitivity are presently limited and further research is needed on the subject.We aim to recruit 20 postmenopausal women already using HRT, who are normally fit and well, to use the testosterone patch for 3 months. The women will be age 45 to 70, willing to continue their current HRT for 6 months and are in a stable relationship. All patients will be asked to give informed consent.We will perform investigations before, during and after the treatment to assess its impact. The investigations will involve blood pressure measurement, waist and hip measurements and blood tests for hormone, glucose and insulin levels. The arterial function will be assessed by 2 non-invasive tests. Firstly using a finger probe to assess changes in blood flow whilst a blood pressure cuff is inflated and secondly using ultrasound to look at the character of the radial pulse. Finally, a questionnaire will be used to assess libido. The study will involve 3 visits over 12 weeks, each lasting between 1-2 hours and will be conducted in NHS hospital sites.
REC name
London - West London & GTAC Research Ethics Committee
REC reference
09/H0707/68
Date of REC Opinion
2 Dec 2009
REC opinion
Further Information Favourable Opinion